Sign in
4

Changes in Ownership

ENANTA PHARMACEUTICALS INC Filed Acc 0001062993-24-020384

Chief Business Officer sold 2,283 shares at $8.06 ($18,401)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Luu Brendan Chief Business Officer 2024-12-06 Sale 10b5-1 −2,283 $8.06 $18,401 36,047 D
Open-market sales · 2,283 sh · avg $8.06 · $18,401
Loading xslF345X05/form4.xml…